Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 06/30/2023 | 96,250,954 | Total gross of voting rights: 96,250,954 |
| Total net* of voting rights: 96,100,982 |
* Net total = total number of voting rights attached to shares – shares without voting rights = 96,250,954 –149,972= 96,100,982
| Last Trade: | US$12.91 |
| Daily Volume: | 0 |
| Market Cap: | US$463.930M |
November 11, 2025 October 28, 2025 October 06, 2025 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
